Group One Trading, L.P. Evelo Biosciences, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$1.86 - $41.8 $21,868 - $491,442	-11,757 Reduced 51.48%	11,082 $23,000
Q2 2022 Aug 11, 2022	SELL	$1.46 - $3.55 $627,946 - $1.53 Million	-430,100 Reduced 94.96%	22,839 $48,000
Q1 2022 May 12, 2022	BUY	$2.66 - $6.63 $868,835 - $2.17 Million	326,630 Added 258.6%	452,939 $1.54 Million
Q4 2021 Feb 11, 2022	BUY	$6.07 - $12.0 $766,695 - $1.52 Million	126,309 New	126,309 $767,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.